Evidence map›Paper›PMID 30658482›Full record

ArticleAntibiotics (Basel, Switzerland)2019

Degradation Kinetics of Clavulanic Acid in Fermentation Broths at Low Temperatures.

David Gómez-Ríos, Howard Ramírez-Malule, Peter Neubauer, Stefan Junne, Rigoberto Ríos-Estepa

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Clavulanic Acid Production byAntibiotics (Basel, Switzerland) · 2021
    Review
  5. Article
  6. Characterization of the Metabolic Response ofAntibiotics (Basel, Switzerland) · 2019
    Article
  7. Comparative Transcriptome Analysis ofAntibiotics (Basel, Switzerland) · 2019
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

David Gómez-RíosGrupo de Bioprocesos, Departamento de Ingeniería Química, Universidad de Antioquia UdeA, Calle 70 No. 52-21, Medellín 050010, Colombia. dandres.gomez@udea.edu.co.ORCID 0000-0002-9858-9559
Howard Ramírez-MaluleEscuela de Ingeniería Química, Universidad del Valle, A.A. 25360, Cali 76001, Colombia. howard.ramirez@correounivalle.edu.co.ORCID 0000-0003-1013-5809
Peter NeubauerChair of Bioprocess Engineering, Institute of Biotechnology, Technische Universität Berlin, Ackerstr. 76, ACK 24, 13355 Berlin, Germany. peter.neubauer@tu-berlin.de.
Stefan JunneChair of Bioprocess Engineering, Institute of Biotechnology, Technische Universität Berlin, Ackerstr. 76, ACK 24, 13355 Berlin, Germany. stefan.junne@tu-berlin.de.
Rigoberto Ríos-EstepaGrupo de Bioprocesos, Departamento de Ingeniería Química, Universidad de Antioquia UdeA, Calle 70 No. 52-21, Medellín 050010, Colombia. rigoberto.rios@udea.edu.co.ORCID 0000-0002-3287-7056
Technische Universität Berlin · DEUniversidad de Antioquia · COUniversidad del Valle · CO

Funding

Departamento Administrativo de Ciencia, Tecnología e Innovación 111577657246 CT 432-2017
6 · The paper itself

Abstract

Clavulanic acid (CA) is a β-lactam antibiotic inhibitor of β-lactamase enzymes, which confers resistance to bacteria against several antibiotics. CA is produced in submerged cultures by the filamentous Gram-positive bacterium

Indexed as

clavulanic aciddegradationequilibriumfermentation brothimidazoleirreversiblekineticslow temperaturereaction mechanism

Identifiers

PMID30658482
PMCPMC6466556
OpenAlexW2909235948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.